Asston Pharmaceuticals Ltd
Asston Pharmaceuticals Ltd (APL) last traded at ₹81, a market capitalisation of ₹69 crore, on a P/E of 17.8. Over the past 52 weeks the stock has ranged between ₹60 and ₹112. Asston Pharmaceuticals Ltd last reported results for the quarter ended Mar 2026, with sales of ₹10.05 crore and net profit of ₹0.48 crore. Figures are as of 25 Aug 2026 and are not real time.
Asston Pharmaceuticals Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Asston Pharmaceuticals Ltd quarterly results
| ₹ crore | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 15.97 | 9.07 | 15.42 | 10.05 |
| Expenses | 13.71 | 5.89 | 13.19 | 12.85 |
| Operating profit | 2.26 | 3.18 | 2.23 | -2.8 |
| OPM % | 14.15% | 35.06% | 14.46% | -27.86% |
| Other income | 0.64 | -0.07 | -1.86 | 4.63 |
| Interest | 0.42 | 0.53 | 0.28 | 0.36 |
| Depreciation | 0.02 | 0.02 | 0.07 | 0.25 |
| Profit before tax | 2.46 | 2.56 | 0.02 | 1.22 |
| Tax % | 22.76% | 23.44% | -50.00% | 59.84% |
| Net profit | 1.9 | 1.95 | 0.03 | 0.48 |
| EPS (₹) | 24.24 | 3.11 | 0.04 | 0.56 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Asston Pharmaceuticals Ltd annual results
| ₹ crore | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Sales | 9.6 | 6.54 | 16.03 | 25.04 | 25.47 |
| Operating profit | -0.36 | 1.52 | 3.82 | 5.44 | -0.57 |
| OPM % | -3.75% | 23.24% | 23.83% | 21.73% | -2.24% |
| Net profit | 0.11 | 1.06 | 2.43 | 3.85 | 3.87 |
| EPS (₹) | 1.57 | 15.14 | 31.00 | 6.14 | 4.55 |
TTM is the trailing twelve months to the most recent quarter.
Asston Pharmaceuticals Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 57%
- TTM
- 2%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 54%
- TTM
- 2%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- 1 Year
- -19%
- 10 Years
- %
- 5 Years
- 28%
- 3 Years
- 26%
- Last Year
- 16%
Asston Pharmaceuticals Ltd shareholding pattern
Promoters held 50.66% at Mar 2026, broadly unchanged since Sep 2025. FIIs 1.91%.
| % held | Sep 2025 | Mar 2026 |
|---|---|---|
| Promoters | 50.66% | 50.66% |
| FIIs | 6.04% | 1.91% |
| Public | 43.30% | 47.41% |
| No. of shareholders | 751 | 687 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Track Asston Pharmaceuticals Ltd
Cruxal reads every Asston Pharmaceuticals Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.